Navigating the area of end-of-life care and access to medications like this drug in New South Wales, NSW, requires a careful comprehension of the complex legal framework. Currently, Pentobarbital does not have a official place on the Pharmaceutical Benefits Scheme (the scheme) and is therefore not routinely prescribed by clinical professionals. Its